Skip to Main Content

Paper Details

Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors.
JAMA Oncol
6
2018
Author NameAffiliation
Jessica K PaulusInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center
  • 1 - 1

Datasets

Release 1.2